View Single Post
Old 12-10-2023, 05:49 PM   #1
Nguyen
Senior Member
 
Join Date: Nov 2005
Posts: 523
All Relevant Subgroups With ESR1-Mutant MBC Derive PFS Benefit With Elacestrant

All Relevant Subgroups With ESR1-Mutant MBC Derive PFS Benefit With Elacestrant

https://www.oncnursingnews.com/view/...th-elacestrant

"...In patients with HER2-low expression, median PFS was 9.03 months vs 1.87 months, respectively (HR, 0.301; 95% CI, 0.142-0.604)..."
Nguyen is offline   Reply With Quote